Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06492759
What this trial is testing

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma
Emory University 29
Large-scale testing (Phase 3)Ended earlyNCT01103388
What this trial is testing

Rituximab Maintenance After Autologous Transplantation

Who this might be right for
Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center 4
Early research (Phase 1)Study completedNCT00006066
What this trial is testing

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Testing effectiveness (Phase 2)UnknownNCT03080922
What this trial is testing

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

Who this might be right for
Leukemia, Myeloid
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Large-scale testing (Phase 3)Study completedNCT03366272
What this trial is testing

Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Who this might be right for
Lymphoma, Non-Hodgkin
Universität des Saarlandes 348
Large-scale testing (Phase 3)Ended earlyNCT00002772
What this trial is testing

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 602
Testing effectiveness (Phase 2)Study completedNCT00002510
What this trial is testing

Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Temple University
Testing effectiveness (Phase 2)UnknownNCT00180791
What this trial is testing

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Who this might be right for
MedulloblastomaBrain TumorsNeuroectodermal Tumors, Primitive
Gustave Roussy, Cancer Campus, Grand Paris 71
Large-scale testing (Phase 3)Study completedNCT00003215
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 400
Testing effectiveness (Phase 2)Study completedNCT00002508
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor
Temple University
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Testing effectiveness (Phase 2)Study completedNCT00572013
What this trial is testing

Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 32
Testing effectiveness (Phase 2)Study completedNCT04091178
What this trial is testing

Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 57
Testing effectiveness (Phase 2)Study completedNCT01255514
What this trial is testing

Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Yonsei University 30
Testing effectiveness (Phase 2)Study completedNCT00003943
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Who this might be right for
Carcinoma of Unknown PrimaryLung Cancer
Fox Chase Cancer Center 3
Not applicableUnknownNCT04406285
What this trial is testing

Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.

Who this might be right for
FatigueLeukemiaLymphoma+1 more
Federal University of Health Science of Porto Alegre 66
Testing effectiveness (Phase 2)Study completedNCT01270724
What this trial is testing

Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

Who this might be right for
CNS Germ Cell Tumor
Nationwide Children's Hospital 10
Early research (Phase 1)Study completedNCT03245892
What this trial is testing

Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer

Who this might be right for
High Grade Serous OvarianFallopian TubePrimary Peritoneal Cancer
Memorial Sloan Kettering Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00970021
What this trial is testing

Agaricus Blazei Murill in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Ullevaal University Hospital 39
Testing effectiveness (Phase 2)UnknownNCT00397800
What this trial is testing

Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Technical University of Munich 12
Next Page